RESTART LIFE SCIENCES CP by Restart Life Sciences Corp. Financials - Benzinga

RESTART LIFE SCIENCES CP by Restart Life Sciences Corp.

NMLSFOTCPK

Trade with Public

Trade with Public

$0.0673

At close: Aug 14, 5:00 PM EST

Overview NewsFinancialsSentiment Compare

RESTART LIFE SCIENCES CP by Restart Life Sciences Corp. Financials

RESTART LIFE SCIENCES CP by Restart Life Sciences Corp. (NMLSF) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Psychedelics And The Spectrum: Groundbreaking Study Details How One Firm Approaches Autism

The partnership between contract research organization KGK Sciences Inc. and Nova Mentis Life Science Corp. (OTC: NMLSF) has started <

Lara Goldstein

Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More

Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and added to the list of measures calling for some sort of psychedelics legalization, while some of the already filed ones continue progressing and others get a thumbs down.

Lara Goldstein